Obsidian Therapeutics Inc. engages in developing cell and gene therapies, particularly for the treatment of solid tumors and cancer. The company was founded on September 29, 2015 and is headquartered in Malvern, PA.
Fundamentals
Mkt Cap
$839.49M
Volume
-
52W High
$49.97
52W Low
$12.16
PE Ratio
0.09
Avg. Volume
691,560.20
EPS (Annual)
$302.63
P/B
-0.01
Rev/Employee
$0.00
Earnings
-
42
Bearish Sentiment
How do you feel about OBX?
RemitTekram
$OBX Have to remember to buy you on dips as IOVA has proven your therapy using TIL. A 2027 win possibly after MM's pound you down.